Asian study of clopidogrel (ASCLOP) responsiveness: the contributions of genetic and non-genetic factors

Int J Cardiol. 2014 Feb 1;171(2):e21-3. doi: 10.1016/j.ijcard.2013.11.126. Epub 2013 Dec 12.

Authors

Doreen S Y Tan¹, Angie H L Yeo², Han Kiat Ho², Hwee Lin Wee², Hean Yee Ong³

Affiliations

¹ Department of Pharmacy, Khoo Teck Puat Hospital, Ministry of Health, Singapore. Electronic address: tan.doreen.sy@alexandrahealth.com.sg.
² Department of Pharmacy, National University of Singapore, Singapore.
³ Department of Cardiology, Khoo Teck Puat Hospital, Singapore.

PMID: 24377711
DOI: 10.1016/j.ijcard.2013.11.126

No abstract available

Keywords: Asian; CYP2C19; CYP3A; Clopidogrel; Dihydropyridine; PON1.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Asian People / genetics*
Cardiovascular Diseases / drug therapy*
Cardiovascular Diseases / genetics*
Clopidogrel
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Precision Medicine
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine